Media Coverage The Market Herald | Avecho Biotechnology (ASX:AVE) releases results from its Phase I trial of CBD soft-ge December 8, 2021December 9, 2021
Company Announcement Ethics Approval for CBD Topical Osteoarthritis Study October 21, 2021October 21, 2021
Company Announcement Dosing commences for Phase I human clinical trial October 4, 2021October 4, 2021
Company Announcement Enrolment commences for Phase I human clinical trial September 15, 2021September 15, 2021
Media Coverage Cannabiz | S3 registration will be a game of skill, not speed August 25, 2021August 25, 2021